Nearly 450 drugs for neurological disorders are in the pipeline

07/31/2013 | Drug Store News

Pharmaceutical Research and Manufacturers of America reported Wednesday that 444 drugs intended to treat neurological disorders are in clinical development or being reviewed by the FDA. "Despite the incredible complexity of neurological disorders, biopharmaceutical scientists have delivered significant advances for patients in recent years, including new medicines for multiple sclerosis and Huntington's diseases," said John J. Castellani, PhRMA's president and CEO.

View Full Article in:

Drug Store News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT